Hematology TimesCSF p-Tau predicts neurocognitive sequelae in survivors of childhood cancerJune 28, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsT receptor diversity may predict BCP-ALL response to blinatumomabJune 26, 2017ALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsMidostaurin improves survival in new AMLJune 24, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsGilteritinib shows safety, efficacy in relapsed/refractory AMLJune 24, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsInfections may trigger leukemia in the genetically susceptibleJune 23, 2017ALLLeukemia, Myelodysplasia, TransplantationPediatrics
Hematology NewsOptimizing therapy in relapsed CLL: ibrutinib and beyondJune 23, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsPatch is early indicator of temperature rise after HSCTJune 23, 2017Cellular TherapyLeukemia, Myelodysplasia, Transplantation
Hematology NewsAntibody from AML survivor may prove therapeuticJune 23, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDA approves rituximab + hyaluronidase human for FL, DLBCL, and CLLJune 22, 2017CLLAggressive LymphomasLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsLenalidomide consolidation linked to extended overall survival in non-del(11q) CLLJune 22, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsSequential triple therapy produces high response rates in CLLJune 21, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCompany discontinues phase 3 trial of vadastuximab talirine in AMLJune 20, 2017Leukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesNeurotoxicity needs separate treatment from CRS in CAR T-cell therapyJune 18, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesCAR T cells plus ibrutinib induce CLL remissionsJune 17, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology Times‘Admirable’ overall survival attainable in AML with enasidenibJune 16, 2017Leukemia, Myelodysplasia, TransplantationAML
